Oncolytics Biotech Stock Technical Analysis
| ONCY Stock | USD 1.02 0.04 4.08% |
As of the 19th of February, Oncolytics Biotech holds the Risk Adjusted Performance of 0.0099, coefficient of variation of 66421.43, and Semi Deviation of 4.49. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncolytics Biotech, as well as the relationship between them.
Oncolytics Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Oncolytics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OncolyticsOncolytics | Build AI portfolio with Oncolytics Stock |
Oncolytics Biotech Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 5.53 | Buy | 6 | Odds |
Most Oncolytics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Oncolytics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Oncolytics Biotech, talking to its executives and customers, or listening to Oncolytics conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncolytics Biotech. Anticipated expansion of Oncolytics directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Oncolytics Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Oncolytics Biotech requires distinguishing between market price and book value, where the latter reflects Oncolytics's accounting equity. The concept of intrinsic value - what Oncolytics Biotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Oncolytics Biotech's price substantially above or below its fundamental value.
It's important to distinguish between Oncolytics Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oncolytics Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Oncolytics Biotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Oncolytics Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncolytics Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncolytics Biotech.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Oncolytics Biotech on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Oncolytics Biotech or generate 0.0% return on investment in Oncolytics Biotech over 90 days. Oncolytics Biotech is related to or competes with Atossa Genetics, Immix Biopharma, Whitehawk Therapeutics, Instil Bio, Zentalis Pharmaceuticals, MacroGenics, and Tevogen Bio. Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of phar... More
Oncolytics Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncolytics Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncolytics Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.82 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 35.26 | |||
| Value At Risk | (7.62) | |||
| Potential Upside | 12.64 |
Oncolytics Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncolytics Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncolytics Biotech's standard deviation. In reality, there are many statistical measures that can use Oncolytics Biotech historical prices to predict the future Oncolytics Biotech's volatility.| Risk Adjusted Performance | 0.0099 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.0003) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oncolytics Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oncolytics Biotech February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0099 | |||
| Market Risk Adjusted Performance | 0.0097 | |||
| Mean Deviation | 4.21 | |||
| Semi Deviation | 4.49 | |||
| Downside Deviation | 4.82 | |||
| Coefficient Of Variation | 66421.43 | |||
| Standard Deviation | 6.2 | |||
| Variance | 38.49 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.0003) | |||
| Maximum Drawdown | 35.26 | |||
| Value At Risk | (7.62) | |||
| Potential Upside | 12.64 | |||
| Downside Variance | 23.28 | |||
| Semi Variance | 20.2 | |||
| Expected Short fall | (5.15) | |||
| Skewness | 1.87 | |||
| Kurtosis | 6.0 |
Oncolytics Biotech Backtested Returns
Oncolytics Biotech appears to be dangerous, given 3 months investment horizon. Oncolytics Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.035, which implies the firm had a 0.035 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Oncolytics Biotech, which you can use to evaluate the volatility of the company. Please evaluate Oncolytics Biotech's Coefficient Of Variation of 66421.43, risk adjusted performance of 0.0099, and Semi Deviation of 4.49 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Oncolytics Biotech holds a performance score of 2. The company holds a Beta of 1.96, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oncolytics Biotech will likely underperform. Please check Oncolytics Biotech's daily balance of power, relative strength index, as well as the relationship between the downside variance and total risk alpha , to make a quick decision on whether Oncolytics Biotech's historical price patterns will revert.
Auto-correlation | 0.28 |
Poor predictability
Oncolytics Biotech has poor predictability. Overlapping area represents the amount of predictability between Oncolytics Biotech time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncolytics Biotech price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Oncolytics Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Oncolytics Biotech Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Oncolytics Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Oncolytics Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Oncolytics Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Oncolytics Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Oncolytics Biotech price pattern first instead of the macroeconomic environment surrounding Oncolytics Biotech. By analyzing Oncolytics Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Oncolytics Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Oncolytics Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Net Debt To EBITDA | 0.49 | 0.47 | Intangibles To Total Assets | 0.0149 | 0.0141 |
Oncolytics Biotech February 19, 2026 Technical Indicators
Most technical analysis of Oncolytics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oncolytics from various momentum indicators to cycle indicators. When you analyze Oncolytics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0099 | |||
| Market Risk Adjusted Performance | 0.0097 | |||
| Mean Deviation | 4.21 | |||
| Semi Deviation | 4.49 | |||
| Downside Deviation | 4.82 | |||
| Coefficient Of Variation | 66421.43 | |||
| Standard Deviation | 6.2 | |||
| Variance | 38.49 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.0003) | |||
| Maximum Drawdown | 35.26 | |||
| Value At Risk | (7.62) | |||
| Potential Upside | 12.64 | |||
| Downside Variance | 23.28 | |||
| Semi Variance | 20.2 | |||
| Expected Short fall | (5.15) | |||
| Skewness | 1.87 | |||
| Kurtosis | 6.0 |
Oncolytics Biotech February 19, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Oncolytics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 72,238 | ||
| Daily Balance Of Power | 0.67 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 1.01 | ||
| Day Typical Price | 1.01 | ||
| Price Action Indicator | 0.03 |
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.